Bayesian Optimization Meets Explainable AI: Enhanced Chronic Kidney Disease Risk Assessment
Mathematics · 25.08.2025 · 13 (17) · 2726
DOI: 10.3390/math13172726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematics, online erschienen am 25.08.2025. Verfasst von Jianbo Huang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Guangxi Science and Technology Major Program.
Abstract (Originalsprache)
Chronic kidney disease (CKD) affects over 850 million individuals worldwide, yet conventional risk stratification approaches fail to capture complex disease progression patterns. Current machine learning approaches suffer from inefficient parameter optimization and limited clinical interpretability. We developed an integrated framework combining advanced Bayesian optimization with explainable artificial intelligence for enhanced CKD risk assessment. Our approach employs XGBoost ensemble learning with intelligent parameter optimization through Optuna (a Bayesian optimization framework) and comprehensive interpretability analysis using SHAP (SHapley Additive exPlanations) to explain model predictions. To address algorithmic “black-box” limitations and enhance clinical trustworthiness, we implemented four-tier risk stratification using stratified cross-validation and balanced evaluation metrics that ensure equitable performance across all patient risk categories, preventing bias toward common cases while maintaining sensitivity for high-risk patients. The optimized model achieved exceptional performance with 92.4% accuracy, 91.9% F1-score, and 97.7% ROC-AUC, significantly outperforming 16 baseline algorithms by 7.9–18.9%. Bayesian optimization reduced computational time by 74% compared to traditional grid search while maintaining robust generalization. Model interpretability analysis identified CKD stage, albumin-creatinine ratio, and estimated glomerular filtration rate as primary predictors, fully aligning with established clinical guidelines. This framework delivers superior predictive accuracy while providing transparent, clinically-meaningful explanations for CKD risk stratification, addressing critical challenges in medical AI deployment: computational efficiency, algorithmic transparency, and equitable performance across diverse patient populations.
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Guangxi Science and Technology Major Program
- The Key Research and Development Program of Guangxi
- Key Laboratory of Equipment Data Security and Guarantee Technology, Ministry of Education
- Natural Science Foundation of Guangxi Province
- Basic Scientific Research Ability Improvement Project for Young and Middle-aged Teachers of Guangxi Higher Education Institutions
Zitieren
APA
Huang, J., Li, L., Hou, M., & Chen, J. (2025). Bayesian Optimization Meets Explainable AI: Enhanced Chronic Kidney Disease Risk Assessment. Mathematics, 13(17), 2726. https://doi.org/10.3390/math13172726
Vancouver
Huang J, Li L, Hou M, Chen J. Bayesian Optimization Meets Explainable AI: Enhanced Chronic Kidney Disease Risk Assessment. Mathematics. 2025;13(17):2726. doi:10.3390/math13172726
BibTeX
@article{Huang2025,
author = {Huang, Jianbo and Li, Long and Hou, Mengdi and Chen, Jia},
title = {Bayesian Optimization Meets Explainable AI: Enhanced Chronic Kidney Disease Risk Assessment},
journal = {Mathematics},
year = {2025},
volume = {13},
number = {17},
pages = {2726},
doi = {10.3390/math13172726}
}
EUVIMED